Stock Scorecard
Stock Summary for Cronos Group Inc (CRON) - $2.69 as of 1/29/2026 9:19:01 AM EST
Total Score
15 out of 30
Safety Score
23 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for CRON
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for CRON
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for CRON
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for CRON
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for CRON (23 out of 100)
| Stock Price Rating (Max of 10) | 3 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 7 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 6 |
| Analyst Buy Ratings (Max of 5) | 2 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for CRON
Financial Details for CRON
Company Overview |
|
|---|---|
| Ticker | CRON |
| Company Name | Cronos Group Inc |
| Country | N/A |
| Description | Cronos Group Inc. is a leading cannabinoid company based in Toronto, Canada, focused on the development and commercialization of innovative cannabis products for both medical and recreational markets. The company distinguishes itself through a strong commitment to research and development, driving advancements in cannabis science to deliver high-quality products. With strategic partnerships and targeted investments, Cronos is expanding its global presence, positioning itself as a key player in the rapidly evolving cannabis industry. As the market continues to grow, Cronos is well-equipped to leverage emerging opportunities and enhance its competitive advantage. |
| Sector Name | HEALTHCARE |
| Industry Name | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/26/2026 |
Stock Price History |
|
| Last Day Price | 2.69 |
| Price 4 Years Ago | 2.54 |
| Last Day Price Updated | 1/29/2026 9:19:01 AM EST |
| Last Day Volume | 1,392,294 |
| Average Daily Volume | 2,830,410 |
| 52-Week High | 3.43 |
| 52-Week Low | 1.60 |
| Last Price to 52 Week Low | 68.13% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 127.45 |
| Sector PE | 125.03 |
| 5-Year Average PE | -242.97 |
| Free Cash Flow Ratio | 1.31 |
| Industry Free Cash Flow Ratio | 12.03 |
| Sector Free Cash Flow Ratio | 27.44 |
| Current Ratio Most Recent Quarter | 22.45 |
| Total Cash Per Share | 2.05 |
| Book Value Per Share Most Recent Quarter | 2.83 |
| Price to Book Ratio | 0.98 |
| Industry Price to Book Ratio | 9.41 |
| Sector Price to Book Ratio | 7.34 |
| Price to Sales Ratio Twelve Trailing Months | 8.04 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.96 |
| Sector Price to Sales Ratio Twelve Trailing Months | 22.65 |
| Analyst Buy Ratings | 1 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 382,893,000 |
| Market Capitalization | 1,029,982,170 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 238.80% |
| Annual Earnings Growth | 155.54% |
| Reported EPS 12 Trailing Months | 0.11 |
| Reported EPS Past Year | 0.00 |
| Reported EPS Prior Year | 0.15 |
| Net Income Twelve Trailing Months | 36,098,000 |
| Net Income Past Year | 41,080,000 |
| Net Income Prior Year | -73,963,000 |
| Quarterly Revenue Growth YOY | 6.10% |
| 5-Year Revenue Growth | 37.71% |
| Operating Margin Twelve Trailing Months | -13.80% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 784,170,000 |
| Total Cash Past Year | 858,805,000 |
| Total Cash Prior Year | 669,291,000 |
| Net Cash Position Most Recent Quarter | 784,170,000 |
| Net Cash Position Past Year | 858,805,000 |
| Long Term Debt Past Year | 0 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 0 |
| Equity to Debt Ratio Past Year | 1.00 |
| Equity to Debt Ratio Most Recent Quarter | 1.00 |
| Total Stockholder Equity Past Year | 1,064,063,000 |
| Total Stockholder Equity Prior Year | 1,099,571,000 |
| Total Stockholder Equity Most Recent Quarter | 1,082,504,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -5,739,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.01 |
| Free Cash Flow Past Year | 5,689,000 |
| Free Cash Flow Prior Year | -46,258,000 |
Options |
|
| Put/Call Ratio | 0.05 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 1.06 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 2.16 |
| 200-Day SMA | 2.34 |
System |
|
| Modified | 1/28/2026 8:45:09 PM EST |